| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 580 |
| 1 | CAPECITABINE | 551 |
| 2 | DOCETAXEL | 511 |
| 3 | DOCETAXEL ANHYDROUS | 511 |
| 4 | FULVESTRANT | 468 |
| 5 | LETROZOLE TABLETS | 453 |
| 6 | PACLITAXEL | 450 |
| 7 | TRASTUZUMAB | 444 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 414 |
| 9 | DENOSUMAB | 402 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VINORELBINE | 148 | 0.0212 |
| 1 | ADO-TRASTUZUMAB EMTANSINE | 157 | 0.0186 |
| 2 | CABAZITAXEL | 62 | 0.0176 |
| 3 | RADIUM RA 223 DICHLORIDE | 74 | 0.0146 |
| 4 | FULVESTRANT | 468 | 0.0140 |
| 5 | EXEMESTANE | 277 | 0.0129 |
| 6 | EVEROLIMUS TABLETS | 192 | 0.0112 |
| 7 | GOSERELIN | 149 | 0.0110 |
| 8 | RIBOCICLIB | 337 | 0.0103 |
| 9 | LAPATINIB | 151 | 0.0098 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 988 |
| 1 | Microtubule Inhibitor [EPC] | 889 |
| 2 | Aromatase Inhibitor [EPC] | 861 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 777 |
| 4 | Platinum-based Drug [EPC] | 763 |
| 5 | Corticosteroid [EPC] | 684 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 481 |
| 7 | Estrogen Receptor Antagonist [EPC] | 472 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 462 |
| 9 | Alkylating Drug [EPC] | 403 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 472 | 0.0116 |
| 1 | Actinomycin [EPC] | 19 | 0.0086 |
| 2 | Aromatase Inhibitor [EPC] | 861 | 0.0076 |
| 3 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 462 | 0.0062 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 117 | 0.0055 |
| 6 | Microtubule Inhibitor [EPC] | 889 | 0.0054 |
| 7 | Dopamine-2 Receptor Antagonist [EPC] | 40 | 0.0051 |
| 8 | Adrenal Steroid Synthesis Inhibitor [EPC] | 5 | 0.0050 |
| 9 | Endoglycosidase [EPC] | 9 | 0.0049 |